Mr. Yong-Feng Cheng | Organic Chemistry | Best Researcher Award

Mr. Yong-Feng Cheng | Organic Chemistry | Best Researcher Award

Mr. Yong-Feng Cheng , Organic Chemistry, Anhui Normal University, China

Dr. Yong-Feng Cheng is an Associate Professor at the School of Chemistry and Materials Science, Anhui Normal University, China. He is a leading researcher in the field of radical chemistry and enantioselective catalysis. After earning his Ph.D. in Organic Chemistry from Nankai University, he pursued postdoctoral and faculty roles at the Southern University of Science and Technology, where he made significant contributions to copper-catalyzed asymmetric transformations. Dr. Cheng’s research, published in prestigious journals such as Nature Chemistry, JACS, and Nature Catalysis, emphasizes radical-based bond-forming reactions and novel catalytic systems. With a solid background in pharmacy and pharmaceutical analysis, he bridges organic synthesis with potential bioactive molecule development. His work is characterized by mechanistic insight, innovation in catalyst design, and collaboration with renowned scientists like Prof. X. Liu and Prof. K.N. Houk. Dr. Cheng continues to push boundaries in modern synthetic chemistry, mentoring students and contributing to cutting-edge discoveries.

Professional Profile :         

Orcid

Scopus  

Summary of Suitability for Award:

Assoc. Prof. Yong-Feng Cheng stands out as a highly suitable candidate for the “Best Researcher Award” . Based on his exceptional publication record, breakthrough contributions to enantioselective radical chemistry, rapid career advancement, and international collaboration, Assoc. Prof. Yong-Feng Cheng is highly deserving of the “Best Researcher Award.” His work reflects a balance of innovation, depth, and scientific rigor, and he has already made a significant mark in modern synthetic chemistry. Granting him this recognition would not only honor a deserving candidate but also inspire broader excellence in chemical sciences.

🎓Education:

Yong-Feng Cheng began his academic journey with a Bachelor’s degree in Pharmacy from Wannan Medical College (2005–2009). Motivated by a strong interest in the analytical and chemical aspects of drug development, he pursued a Master of Science in Pharmaceutical Analysis at Tianjin University of Traditional Chinese Medicine (2009–2012). His growing passion for organic synthesis led him to Nankai University, where he earned his Ph.D. in Organic Chemistry (2012–2015). At Nankai, he specialized in developing synthetic methodologies and advanced radical transformations. His doctoral training laid a solid foundation for his future work in radical catalysis. With this multidisciplinary education—spanning pharmacy, analytical science, and organic chemistry—Dr. Cheng brings a uniquely integrated perspective to the development of functional molecules and asymmetric synthesis. His academic background enables him to innovate at the intersection of fundamental chemistry and potential therapeutic applications.

🏢Work Experience:

Dr. Yong-Feng Cheng has steadily advanced through competitive academic roles in China’s premier institutions. From 2016 to 2018, he worked as a postdoctoral fellow at the Southern University of Science and Technology (SUSTech), collaborating on pioneering research in enantioselective radical transformations. Recognized for his innovative approach, he was promoted to Research Assistant Professor at SUSTech (2018–2022), where he co-authored several high-impact papers and contributed significantly to catalyst development. In 2023, he joined Anhui Normal University as an Associate Professor in the School of Chemistry and Materials Science. His current role involves leading a research group focused on asymmetric catalysis, mentoring graduate students, and securing national research grants. With a blend of research acumen and teaching excellence, Dr. Cheng continues to shape the future of synthetic chemistry, integrating his deep understanding of radicals, catalysis, and reaction mechanisms across disciplines.

🏅Awards: 

While the specific awards and honors of Dr. Yong-Feng Cheng are not explicitly listed, his track record of publishing in journals like Nature Chemistry, JACS, and Angewandte Chemie reflects high recognition in the international scientific community. Being co-first and corresponding author in several high-impact papers demonstrates peer acknowledgment of his leading role in radical catalysis. His research collaborations with globally renowned scientists like Prof. K.N. Houk and Prof. X. Liu further validate his standing as an innovative researcher. His rapid career progression—from Ph.D. to Associate Professor in under a decade—is itself a testimony to his scientific excellence. He has likely received institutional recognition for teaching and research performance and may have earned national-level research grants or young scientist accolades. As his work continues to draw citations and attention, more formal honors are anticipated in the near future.

🔬Research Focus:

Dr. Yong-Feng Cheng’s research is centered on enantioselective radical transformations, with a focus on copper-catalyzed asymmetric reactions. His work explores the interface of Organic chemistry and catalysis, developing novel methodologies for constructing C–O, S–O, and C–C bonds with high stereo control. His synthetic strategies employ innovative ligand systems and cooperative catalysis to achieve de- symmetrization and functionalization of otherwise inert molecules. Dr. Cheng has contributed significantly to the design of catalytic systems that enable precise manipulation of reactive radical intermediates, with potential applications in pharmaceuticals, agrochemicals, and material science. He is particularly interested in mechanistic insights, transition-state modeling, and computational collaboration to understand catalytic pathways. With a strong background in both pharmacy and organic synthesis, Dr. Cheng’s research is both methodologically rigorous and application-oriented. His group continues to develop sustainable and scalable reactions for asymmetric synthesis, including redox-triggered transformations and metal-catalyzed coupling strategies.

Publication Top Notes:

1. A P‐nucleophile Interrupted Seyferth‐Gilbert Reaction

2. Synthesis of Axially Chiral Vinyl Halides via Cu(I)-Catalyzed Enantioselective Radical 1,2-Halofunctionalization of Terminal Alkynes

3. Cu(I)-Catalyzed Chemo- and Enantioselective Desymmetrizing C–O Bond Coupling of Acyl Radicals

4. Cu-Catalyzed Enantioselective Radical Heteroatomic S–O Cross-Coupling

5. Catalytic Enantioselective Desymmetrizing Functionalization of Alkyl Radicals via Cu(I)/CPA Cooperative Catalysis

6. Desymmetrization of Unactivated Bis-Alkenes via Chiral Brønsted Acid-Catalyzed Hydroamination

7. Achiral Pyridine Ligand-Enabled Enantioselective Radical Oxytrifluoromethylation of Alkenes with Alcohols

8. Synthesis of γ-Lactams by Mild, o-Benzoquinone-Induced Oxidation of Pyrrolidines Containing Oxidation-Sensitive Functional Groups

9. Redox-Triggered α-C–H Functionalization of Pyrrolidines: Synthesis of Unsymmetrically 2,5-Disubstituted Pyrrolidines

10. A New Practical Approach Towards the Synthesis of Unsymmetric and Symmetric 1,10-Phenanthroline Derivatives at Room Temperature

 

Khalid M. Khan | Organic Chemistry | Best Researcher Award 1356

Khalid M. Khan | Organic Chemistry | Best Researcher Award

Profosser at Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi 75270, Pakistan Pakistan

Prof. Dr. Khalid Mohammed Khan is a prominent figure in the field of chemistry, specializing in synthetic organic chemistry, bioorganic chemistry, and medicinal chemistry. With a career spanning several decades, he has made significant contributions to research and education in Pakistan and internationally. His expertise is demonstrated through an extensive publication record, numerous patents, and successful mentorship of graduate scholars.

Author Metrics

Scopus Profile 

Google Scholar Profile

 ORCID Profile

Prof. Khan’s scholarly impact is underscored by impressive author metrics: he has published a total of 909 research papers, with 750 in international journals and 159 in national publications. His work has a cumulative impact factor of 1759.750, with over 21,060 citations. He maintains a Google Scholar h-index of 70 and an i10-index of 492, indicating his substantial influence in the scientific community.

Education

Dr. Khan’s academic journey began with a B.Sc. in 1982 from Sindh University, followed by an M.Sc. in Organic Chemistry from Quaid-i-Azam University. He completed his Ph.D. in 1991 at the H. E. J. Research Institute of Chemistry under the supervision of Prof. Dr. Mohammed Saleh Shekhani. He furthered his education with postdoctoral fellowships in Germany and at his home institution, leading to a D.Sc. degree in 2022.

Research Focus

His research interests include synthetic organic chemistry, medicinal chemistry, and the development of bioactive compounds. Dr. Khan has focused on the synthesis and evaluation of various organic molecules, particularly in relation to their therapeutic applications against diseases like diabetes and cancer. His work also emphasizes innovative synthetic methodologies.

Professional Journey

Prof. Khan’s professional career has evolved significantly, from serving as an Assistant Professor to attaining his current position as a Professor at the H. E. J. Research Institute of Chemistry. He has held various administrative roles, including acting director and coordinator for numerous programs. His contributions to quality control in pharmaceutical industries reflect his commitment to advancing both academia and industry standards.

Honors & Awards

His achievements have been recognized with several prestigious awards, including the Sitara-i-Imtiaza and Tamgha-i-Imtiaz from the Government of Pakistan, as well as fellowships from esteemed organizations like TWAS and the Royal Society of Chemistry. His leadership roles in national chemistry societies further underscore his influence in the scientific community.

Publications Noted & Contributions

Dr. Khan has co-edited both international and national books and authored 14 book chapters. His extensive list of publications includes 17 international patents and 4 national patents, showcasing his innovative contributions to chemical research. He has played a crucial role in mentoring 101 M.Phil. and Ph.D. scholars, significantly contributing to the academic landscape.

  • 2-amino-6-ethoxy-4-arylpyridine-3,5-dicarbonitrile Scaffolds as Potential Acetylcholinesterase and Butyrylcholinesterase Inhibitors
  • Imidazole‐Thiadiazole Hybrids: A Multitarget De Novo Drug Design Approach, In Vitro Evaluation, ADME/T, and In Silico Studies
    • Journal: Archiv der Pharmazie
    • Published: September 2024
    • DOI: 10.1002/ardp.202400325
    • Contributors: Maryam Maqbool et al.
  • Exploring Diabetics II Inhibitors Based on Benzodioxin Derivatives, Structure Activity Relationship, Molecular Docking and ADME Property Study
  • Nicotinonitriles as Potential Inhibitors of α-glucosidase, Tyrosinase, and Urease Enzymes: Synthesis, Characterization, In Vitro, and In Silico Studies
  • Synthesis of Benzimidazoles Containing Piperazine Ring as Potential Therapeutic Agents Against Diabetes Mellitus and Antioxidant Activities

Research Timeline

Throughout his career, Dr. Khan has been involved in numerous funded research projects, both nationally and internationally, focusing on the synthesis of biologically active compounds. His research has led to collaborations with various academic institutions and organizations, facilitating the advancement of chemical research in Pakistan.

Conclusion

Prof. Dr. Khalid Mohammed Khan’s exemplary career reflects a deep commitment to scientific advancement and education. His extensive research, mentorship, and leadership in the field of chemistry have made a lasting impact both nationally and internationally. As a respected figure in academia, he continues to inspire the next generation of scientists through his work and contributions to the field.